{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:23:34Z","timestamp":1783405414687,"version":"3.54.6"},"reference-count":120,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008741","name":"European League Against Rheumatism","doi-asserted-by":"publisher","award":["EPI021"],"award-info":[{"award-number":["EPI021"]}],"id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2021,1,14]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To summarise the methodological aspects in studies with work participation (WP) as outcome domain in inflammatory arthritis (IA) and other chronic diseases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Two systematic literature reviews (SLRs) were conducted in key electronic databases (2014\u20132019): search 1 focused on longitudinal prospective studies in IA and search 2 on SLRs in other chronic diseases. Two reviewers independently identified eligible studies and extracted data covering pre-defined methodological areas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 58 studies in IA (22 randomised controlled trials, 36 longitudinal observational studies) and 24 SLRs in other chronic diseases were included. WP was the primary outcome in 26\/58 (45%) studies. The methodological aspects least accounted for in IA studies were as follows (proportions of studies positively adhering to the topic are shown): aligning the studied population (16\/58 (28%)) and sample size calculation (8\/58 (14%)) with the work-related study objective; attribution of WP to overall health (28\/58 (48%)); accounting for skewness of presenteeism\/sick leave (10\/52 (19%)); accounting for work-related contextual factors (25\/58 (43%)); reporting attrition and its reasons (1\/58 (2%)); reporting both aggregated results and proportions of individuals reaching predefined meaningful change or state (11\/58 (16%)). SLRs in other chronic diseases confirmed heterogeneity and methodological flaws identified in IA studies without identifying new issues.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>High methodological heterogeneity was observed in studies with WP as outcome domain. Consensus around various methodological aspects specific to WP studies is needed to improve quality of future studies. This review informs the EULAR Points to Consider for conducting and reporting studies with WP as an outcome in IA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2020-001522","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T14:50:32Z","timestamp":1612450232000},"page":"e001522","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Methodological aspects of design, analysis and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis: results of two systematic literature reviews informing EULAR points to consider"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-9425","authenticated-orcid":false,"given":"Mary Lucy","family":"Marques","sequence":"first","affiliation":[{"name":"Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands"},{"name":"Rheumatology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1105-5640","authenticated-orcid":false,"given":"Alessia","family":"Alunno","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Perugia Department of Medicine, Perugia, Umbria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-9533","authenticated-orcid":false,"given":"Annelies","family":"Boonen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, Limburg, The Netherlands"},{"name":"Department of Health Services Research, Universiteit Maastricht Care and Public Health Research Institute, Maastricht, Limburg, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke M","family":"ter Wee","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Rheumatology and immunology, AI&I, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Falzon","sequence":"additional","affiliation":[{"name":"Center for Personalized Health, Feinstein Institutes for Medical Research, Northwell Health, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ramiro","sequence":"additional","affiliation":[{"name":"Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands"},{"name":"Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, Limburg, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Putrik","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, Limburg, The Netherlands"},{"name":"Department of Health Services Research, Universiteit Maastricht Care and Public Health Research Institute, Maastricht, Limburg, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"2025090312405252000_7.1.e001522.1","first-page":"2315","article-title":"The effect of arthritis on working life expectancy","volume":"28","author":"Lacaille","year":"2001","journal-title":"J Rheumatol"},{"key":"2025090312405252000_7.1.e001522.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23002"},{"key":"2025090312405252000_7.1.e001522.3","first-page":"147","article-title":"Work functioning: a conceptual framework","volume":"23","author":"Sandqvist","year":"2004","journal-title":"Work"},{"key":"2025090312405252000_7.1.e001522.4","first-page":"1372 LP","article-title":"Worker productivity outcome measures in arthritis","volume":"34","author":"Escorpizo","year":"2007","journal-title":"J Rheumatol"},{"key":"2025090312405252000_7.1.e001522.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2015.06.001"},{"key":"2025090312405252000_7.1.e001522.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201914"},{"key":"2025090312405252000_7.1.e001522.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.154583"},{"key":"2025090312405252000_7.1.e001522.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181201"},{"key":"2025090312405252000_7.1.e001522.9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141077"},{"key":"2025090312405252000_7.1.e001522.10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110405"},{"key":"2025090312405252000_7.1.e001522.11","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20633"},{"key":"2025090312405252000_7.1.e001522.12","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e3181a8281b"},{"key":"2025090312405252000_7.1.e001522.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(99)00452-9"},{"key":"2025090312405252000_7.1.e001522.14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev435"},{"key":"2025090312405252000_7.1.e001522.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"2025090312405252000_7.1.e001522.16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.semarthrit.2017.10.009","article-title":"Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: a patient registry study","volume":"47","author":"Alemao","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2025090312405252000_7.1.e001522.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135327"},{"key":"2025090312405252000_7.1.e001522.18","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1002\/art.39805","article-title":"Effect of secukinumab on patient-reported outcomes in patients with active ankylosing spondylitis: a phase III randomized trial (measure 1)","volume":"68","author":"Deodhar","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025090312405252000_7.1.e001522.19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141313"},{"key":"2025090312405252000_7.1.e001522.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-018-1598-8","article-title":"Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients","volume":"20","author":"Druce","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025090312405252000_7.1.e001522.21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew056"},{"key":"2025090312405252000_7.1.e001522.22","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/acr.22899","article-title":"Infliximab versus conventional combination treatment and seven\u2010year work loss in early rheumatoid arthritis: results of a randomized Swedish trial","volume":"68","author":"Eriksson","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2025090312405252000_7.1.e001522.23","first-page":"1","article-title":"The impact of diagnosis on job retention: a Danish registry-based cohort study","volume":"2015","author":"Espersen","year":"2015","journal-title":"Rehabil Res Pract"},{"key":"2025090312405252000_7.1.e001522.24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/acr.22763","article-title":"Patient\u2010reported outcomes from a two\u2010year head\u2010to\u2010head comparison of subcutaneous abatacept and adalimumab for rheumatoid arthritis","volume":"68","author":"Fleischmann","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2025090312405252000_7.1.e001522.25","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key161"},{"key":"2025090312405252000_7.1.e001522.26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10926-014-9537-2","article-title":"Predictors of presenteeism and activity impairment outside work in patients with spondyloarthritis","volume":"25","author":"Haglund","year":"2015","journal-title":"J Occup Rehabil"},{"key":"2025090312405252000_7.1.e001522.27","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/rheumatology\/kex064","article-title":"Work ability in rheumatoid arthritis patients: a register study on the prospective risk of exclusion and probability of returning to work","volume":"56","author":"Hansen","year":"2017","journal-title":"Rheumatology"},{"key":"2025090312405252000_7.1.e001522.28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130864"},{"key":"2025090312405252000_7.1.e001522.29","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150801"},{"key":"2025090312405252000_7.1.e001522.30","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s10067-016-3431-6","article-title":"The effect of total hip replacement on employment in patients with ankylosing spondylitis","volume":"35","author":"He","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2025090312405252000_7.1.e001522.31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1874312901409010046","article-title":"Effect of adalimumab on work ability assessed in rheumatoid arthritis disease patients in Saudi Arabia (AWARDS)","volume":"9","author":"Hussain","year":"2015","journal-title":"Open Rheumatol J"},{"key":"2025090312405252000_7.1.e001522.32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40744-018-0105-7","article-title":"Similar improvements in patient-reported outcomes among rheumatoid arthritis patients treated with two different doses of methotrexate in combination with adalimumab: results from the MUSICA trial","volume":"5","author":"Kaeley","year":"2018","journal-title":"Rheumatol Ther"},{"key":"2025090312405252000_7.1.e001522.33","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000551"},{"key":"2025090312405252000_7.1.e001522.34","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000695"},{"key":"2025090312405252000_7.1.e001522.35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205198"},{"key":"2025090312405252000_7.1.e001522.36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211259"},{"key":"2025090312405252000_7.1.e001522.37","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000055"},{"key":"2025090312405252000_7.1.e001522.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207596"},{"key":"2025090312405252000_7.1.e001522.39","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/acr.23497","article-title":"Is anti-citrullinated protein antibody-positive rheumatoid arthritis still a more severe disease than anti-citrullinated protein antibody-negative rheumatoid arthritis? A longitudinal cohort study in rheumatoid arthritis patients diagnosed from 2000 onward","volume":"70","author":"Boer","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2025090312405252000_7.1.e001522.40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130878"},{"key":"2025090312405252000_7.1.e001522.41","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket373"},{"key":"2025090312405252000_7.1.e001522.42","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00296-016-3518-z","article-title":"Evaluation of the impact of nursing clinics in the rheumatology services","volume":"36","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2016","journal-title":"Rheumatol Int"},{"key":"2025090312405252000_7.1.e001522.43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s12325-018-0866-y","article-title":"Real-world postmarketing study of the impact of adalimumab treatment on work productivity and activity impairment in patients with psoriatic arthritis","volume":"36","author":"Nakagawa","year":"2019","journal-title":"Adv Ther"},{"key":"2025090312405252000_7.1.e001522.44","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210239"},{"key":"2025090312405252000_7.1.e001522.45","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev407"},{"key":"2025090312405252000_7.1.e001522.46","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202911"},{"key":"2025090312405252000_7.1.e001522.47","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/acr.23619","article-title":"Patient\u2010reported outcomes are more important than objective inflammatory markers for sick leave in biologics\u2010treated patients with rheumatoid arthritis","volume":"70","author":"Olofsson","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2025090312405252000_7.1.e001522.48","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/acr.23000","article-title":"Ustekinumab treatment and improvement of physical function and health-related quality of life in patients with psoriatic arthritis","volume":"68","author":"Rahman","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2025090312405252000_7.1.e001522.49","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/rheumatology\/kex087","article-title":"Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials","volume":"56","author":"Rendas-Baum","year":"2017","journal-title":"Rheumatology"},{"key":"2025090312405252000_7.1.e001522.50","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/rheumatology\/kex476","article-title":"Contextual factors influence work outcomes in employed patients with ankylosing spondylitis starting etanercept: 2-year results from AS@Work","volume":"57","author":"Boonen","year":"2018","journal-title":"Rheumatology"},{"key":"2025090312405252000_7.1.e001522.51","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213590"},{"key":"2025090312405252000_7.1.e001522.52","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209821"},{"key":"2025090312405252000_7.1.e001522.53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2217\/ijr.15.40","article-title":"The impact of rheumatoid arthritis on work and predictors of overall work impairment from three therapeutic scenarios","volume":"10","author":"Strand","year":"2015","journal-title":"Int J Clin Rheumtol"},{"key":"2025090312405252000_7.1.e001522.54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13075-018-1614-z","article-title":"Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis","volume":"20","author":"Strand","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025090312405252000_7.1.e001522.55","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2217\/cer-2016-0020","article-title":"Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central\u2013eastern Europe","volume":"5","author":"Sz\u00e1nt\u00f3","year":"2016","journal-title":"J Comp Eff Res"},{"key":"2025090312405252000_7.1.e001522.56","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12325-017-0477-z","article-title":"Impact of adalimumab on work productivity and activity impairment in Japanese patients with rheumatoid arthritis: large-scale, prospective, single-cohort ANOUVEAU study","volume":"34","author":"Takeuchi","year":"2017","journal-title":"Adv Ther"},{"key":"2025090312405252000_7.1.e001522.57","first-page":"88","article-title":"Work disability in Finnish patients with rheumatoid arthritis: a 15-year follow-up","volume":"32","author":"Tiippana-Kinnunen","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312405252000_7.1.e001522.58","first-page":"603","article-title":"Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis","volume":"56","author":"Tillett","year":"2017","journal-title":"Rheumatol"},{"key":"2025090312405252000_7.1.e001522.59","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/acr.22655","article-title":"Longitudinal analyses of presenteeism and its role as a predictor of sick leave in patients with ankylosing spondylitis","volume":"67","author":"Tran-Duy","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2025090312405252000_7.1.e001522.60","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000659"},{"key":"2025090312405252000_7.1.e001522.61","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170586"},{"key":"2025090312405252000_7.1.e001522.62","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131003"},{"key":"2025090312405252000_7.1.e001522.63","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1093\/rheumatology\/kex365","article-title":"Disease activity decrease is associated with improvement in work productivity over 1 year in early axial spondyloarthritis (SPondyloArthritis Caught Early cohort)","volume":"56","author":"van Lunteren","year":"2017","journal-title":"Rheumatology"},{"key":"2025090312405252000_7.1.e001522.64","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/09638288.2016.1145257","article-title":"Effectiveness of an integrated care intervention on supervisor support and work functioning of workers with rheumatoid arthritis","volume":"39","author":"van Vilsteren","year":"2017","journal-title":"Disabil Rehabil"},{"key":"2025090312405252000_7.1.e001522.65","doi-asserted-by":"crossref","first-page":"kew473","DOI":"10.1093\/rheumatology\/kew473","article-title":"Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden","volume":"17","author":"Wallman","year":"2017","journal-title":"Rheumatol"},{"key":"2025090312405252000_7.1.e001522.66","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000766","article-title":"Sick leave and its predictors in ankylosing spondylitis: long-term results from the outcome in ankylosing spondylitis international study","volume":"4","author":"Webers","year":"2018","journal-title":"RMD Open"},{"key":"2025090312405252000_7.1.e001522.67","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/1756-185X.12973","article-title":"Efficacy and safety of etanercept in patients from Latin America, central Europe and Asia with early non-radiographic axial spondyloarthritis","volume":"21","author":"Wei","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2025090312405252000_7.1.e001522.68","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/17843286.2018.1509923","article-title":"Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study","volume":"74","author":"Westhovens","year":"2019","journal-title":"Acta Clin Belg"},{"key":"2025090312405252000_7.1.e001522.69","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151179"},{"key":"2025090312405252000_7.1.e001522.70","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22730"},{"key":"2025090312405252000_7.1.e001522.71","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/1756-185X.13526","article-title":"Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort","volume":"22","author":"Claudepierre","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2025090312405252000_7.1.e001522.72","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204178"},{"key":"2025090312405252000_7.1.e001522.73","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev015"},{"key":"2025090312405252000_7.1.e001522.74","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170778"},{"key":"2025090312405252000_7.1.e001522.75","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3346\/jkms.2014.29.2.190","article-title":"Cost-of-illness and quality of life in patients with ankylosing spondylitis at a tertiary hospital in Korea","volume":"29","author":"Lee","year":"2014","journal-title":"J Korean Med Sci"},{"key":"2025090312405252000_7.1.e001522.76","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150406"},{"key":"2025090312405252000_7.1.e001522.77","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10067-016-3446-z","article-title":"Welfare costs in patients with rheumatoid arthritis and their partners compared with matched controls: a register-based study","volume":"36","author":"L\u00f8ppenthin","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025090312405252000_7.1.e001522.78","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu319"},{"key":"2025090312405252000_7.1.e001522.79","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160103"},{"key":"2025090312405252000_7.1.e001522.80","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40261-016-0491-y","article-title":"Economic burden of rheumatoid arthritis in Italy: possible consequences on anti-citrullinated protein antibody-positive patients","volume":"37","author":"Mennini","year":"2017","journal-title":"Clin Drug Investig"},{"key":"2025090312405252000_7.1.e001522.81","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev023"},{"key":"2025090312405252000_7.1.e001522.82","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1539\/joh.16-0082-OA","article-title":"Economic evaluation of an intervention program with the aim to improve at\u2010work productivity for workers with rheumatoid arthritis","volume":"59","author":"Noben","year":"2017","journal-title":"J Occup Health"},{"key":"2025090312405252000_7.1.e001522.83","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/1756-185X.13277","article-title":"The economic impacts of using adalimumab (Humira \u00ae) for reducing pain in people with ankylosing spondylitis: a microsimulation study for Australia","volume":"21","author":"Schofield","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2025090312405252000_7.1.e001522.84","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1007\/s12325-017-0614-8","article-title":"Modeled health economic impact of a hypothetical certolizumab pegol risk-sharing scheme for patients with moderate-to-severe rheumatoid arthritis in Finland","volume":"34","author":"Soini","year":"2017","journal-title":"Adv Ther"},{"key":"2025090312405252000_7.1.e001522.85","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204080"},{"key":"2025090312405252000_7.1.e001522.86","first-page":"344","article-title":"Economic burden of patients with inadequate response to targeted immunomodulators for rheumatoid arthritis","volume":"24","author":"Strand","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"2025090312405252000_7.1.e001522.87","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14397595.2017.1341459","article-title":"Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study","volume":"28","author":"Tanaka","year":"2018","journal-title":"Mod Rheumatol"},{"key":"2025090312405252000_7.1.e001522.88","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150617"},{"key":"2025090312405252000_7.1.e001522.89","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40801-016-0063-8","article-title":"Estimating the economic burden of rheumatoid arthritis in Taiwan using the national health insurance database","volume":"3","author":"Wang","year":"2016","journal-title":"Drugs - Real World Outcomes"},{"key":"2025090312405252000_7.1.e001522.90","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205060"},{"key":"2025090312405252000_7.1.e001522.91","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/03009742.2017.1420224","article-title":"Costs and disease activity in early rheumatoid arthritis in 1996\u20132000 and 2006\u20132011, improved outcome and shift in distribution of costs: a two-year follow-up","volume":"47","author":"Husberg","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"2025090312405252000_7.1.e001522.92","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204311"},{"key":"2025090312405252000_7.1.e001522.93","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/13696998.2017.1307205","article-title":"Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators","volume":"20","author":"Jansen","year":"2017","journal-title":"J Med Econ"},{"key":"2025090312405252000_7.1.e001522.94","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket290"},{"key":"2025090312405252000_7.1.e001522.95","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210579"},{"key":"2025090312405252000_7.1.e001522.96","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.puhe.2016.07.004","article-title":"The economic impact of early retirement attributed to rheumatic diseases: results from a nationwide population-based epidemiologic study","volume":"140","author":"Laires","year":"2016","journal-title":"Public Health"},{"key":"2025090312405252000_7.1.e001522.97","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2165079918812483","article-title":"Return to work among stroke survivors","volume":"67","author":"Ashley","year":"2019","journal-title":"Workplace Health Saf"},{"key":"2025090312405252000_7.1.e001522.98","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10926-017-9736-8","article-title":"Functional impairments and work-related outcomes in breast cancer survivors: a systematic review","volume":"28","author":"Bijker","year":"2018","journal-title":"J Occup Rehabil"},{"key":"2025090312405252000_7.1.e001522.99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.12968\/ijtr.2017.24.5.203","article-title":"Case management for return to work for individuals living with cancer: a systematic review","volume":"24","author":"McQueen","year":"2017","journal-title":"Int J Ther Rehabil"},{"key":"2025090312405252000_7.1.e001522.100","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s40273-016-0441-9","article-title":"Nocturia work productivity and activity impairment compared with other common chronic diseases","volume":"34","author":"Miller","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"2025090312405252000_7.1.e001522.101","first-page":"2983","article-title":"Return to work in European cancer survivors: a systematic review","volume":"26","author":"Paltrinieri","year":"2018","journal-title":"Support Care Cancer"},{"key":"2025090312405252000_7.1.e001522.102","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/COPD.S57157","article-title":"Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States","volume":"9","author":"Patel","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025090312405252000_7.1.e001522.103","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/occmed\/kqy012","article-title":"Systematic review: Chronic obstructive pulmonary disease and work-related outcomes","volume":"68","author":"Rai","year":"2018","journal-title":"Occup Med"},{"key":"2025090312405252000_7.1.e001522.104","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s11695-016-2367-x","article-title":"Systematic review and meta-analysis of occupational outcomes after bariatric surgery","volume":"27","author":"Sharples","year":"2017","journal-title":"Obes Surg"},{"key":"2025090312405252000_7.1.e001522.105","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1111\/ajco.12515","article-title":"Are cancer survivors well-performing workers? A systematic review","volume":"12","author":"Soejima","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"2025090312405252000_7.1.e001522.106","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11764-017-0614-3","article-title":"Young adult cancer survivors and work: a systematic review","volume":"11","author":"Stone","year":"2017","journal-title":"J Cancer Surviv"},{"key":"2025090312405252000_7.1.e001522.107","first-page":"709","article-title":"Return to work among breast cancer survivors: a literature review","volume":"25","author":"Sun","year":"2017","journal-title":"Support Care Cancer"},{"key":"2025090312405252000_7.1.e001522.108","first-page":"147","article-title":"Return to work in cancer patients: a systematic review and meta-analysis","volume":"25","author":"Tavan","year":"2019","journal-title":"Indian J Palliat Care"},{"key":"2025090312405252000_7.1.e001522.109","first-page":"1993","article-title":"Exploration of return-to-work interventions for breast cancer patients: a scoping review","volume":"25","author":"Bilodeau","year":"2017","journal-title":"Support Care Cancer"},{"key":"2025090312405252000_7.1.e001522.110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/bari.2018.0014","article-title":"The impact of bariatric surgery on employment: a systematic review","volume":"13","author":"Vayr","year":"2018","journal-title":"Bariatr Surg Pract Patient Care"},{"key":"2025090312405252000_7.1.e001522.111","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.03.010"},{"key":"2025090312405252000_7.1.e001522.112","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1200\/JCO.2017.77.3663","article-title":"Predictors of unemployment after breast cancer surgery: a systematic review and meta-analysis of observational studies","volume":"36","author":"Wang","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025090312405252000_7.1.e001522.113","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/0308022615624710","article-title":"Outcomes of return-to-work after stroke rehabilitation: a systematic review","volume":"79","author":"Wei","year":"2016","journal-title":"British Journal of Occupational Therapy"},{"key":"2025090312405252000_7.1.e001522.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.06.006"},{"key":"2025090312405252000_7.1.e001522.115","first-page":"391","article-title":"Development of conceptual framework to understand factors associated with return to work among cancer survivors: a systematic review","volume":"43","author":"Chow","year":"2014","journal-title":"Iran J Public Health"},{"key":"2025090312405252000_7.1.e001522.116","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3467"},{"key":"2025090312405252000_7.1.e001522.117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/1747493017743059","article-title":"Return to work after young stroke: a systematic review","volume":"13","author":"Edwards","year":"2018","journal-title":"Int J Stroke"},{"key":"2025090312405252000_7.1.e001522.118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4073\/csr.2015.5","article-title":"Behavioral, psychological, educational, and vocational interventions to facilitate employment outcomes for cancer survivors: a systematic review","volume":"11","author":"Fong","year":"2015","journal-title":"Campbell Systematic Reviews"},{"key":"2025090312405252000_7.1.e001522.119","first-page":"136","article-title":"A systematic review of the effect of cancer treatment on work productivity of patients and caregivers","volume":"23","author":"Kamal","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"2025090312405252000_7.1.e001522.120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11764-019-00750-4","article-title":"Work after prostate cancer: a systematic review","volume":"13","author":"McLennan","year":"2019","journal-title":"J Cancer Surviv"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2020-001522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:41:08Z","timestamp":1756928468000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2020-001522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2,4]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/rmdopen-2020-001522"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2020-001522","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}